Browsing by Author "Jamiu, M.O."
Now showing 1 - 3 of 3
Results Per Page
Sort Options
Item Evaluation of Direct Medical Cost for HIV/AIDS Management in Iran.(Faculty of Pharmaceutical Sciences, University of Ilorin, Ilorin., 2022) Giwa, H.B.; Giwa, A.; Davari, M.; Jamiu, M.O.; Seyed, A.S.A.; Mohraz, M.; Aiyelero, O.M.Background: Although Iran has a low prevalence of HIV/AIDS, government budgets and developmental assistance in the management of the disease have reduced over the years. Accurate knowledge of direct medical costs is key to developing and prioritizing healthcare policies and interventions, as well as allocating healthcare resources within budget constraints, to achieve policy efficiency. Objective: To evaluate direct medical costs for the management of HIV/AIDS Patients in Iran. Method: A one-year retrospective review of 2000 case notes of HIV/AIDS patients of Imam Khomeini Hospital Tehran (Iranian Research Centre for HIV/AIDS) out of which 322 were selected as the sample size for both Pre-ART and ART patients between January and December 2019. Subsequently, systematic sampling was done, with sampling interval offive . Prevalence rate method is used to determine direct medical costs. Results: Annual cost for management of 322 Pre-ART and 322 ART patients was found to be $191,718 with components of $ 141,492.58 (74%), $48,582.77(25%) and $1,612.92(1%) representing the cost of medications, diagnostic tests and personnel respectively. The main cost driver was found to be medications. The annual cost per prevalent case for HIV/AIDS for Iran was found to be $599.25, with $129.25 representing cost for pre - ART care and $470 for ART care. Conclusion Annual cost per prevalent case of HIV/AIDS was 55% of annual expenditure per capita. This is quite enormous considering other diseases of high burden. The annual National cost for Iran is $ 4.9 Million.Item Prevalence of Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus attending A Secondary Care Hospital in North Central Nigeria(Faculty of Pharmaceutical Sciences, University of Ilorin, 2021-04) Aliyu, Fullaila Onozare; Olorunfemi, O.T; Bello, Shakirat Iyabo; Jamiu, M.O.; Abdulazeez, Iyabo Fatimah; Williams, Felicia E.; Abdulbaki, M., Chronic Kidney Disease (CKD) is a public health problem that is associated with adverse outcomes of kidney failure, diseases of the cardiovascular system and untimely death. The purpose of this study was to determine the prevalence of chronic kidney disease in type 2 diabetes mellitus (DM) patients and to determine kidney staging on the basis of estimated glomerular filtration rate (eGFR) values. One hundred and twenty (120) patients were recruited for the study (mean age 54.7 ±14.701). This study was a prospective cross sectional study among out-patients with Diabetes mellitus in north central Nigeria. A validated questionnaire was used to capture socio-demographics. Informed consent was obtained from each patient and blood samples were collected in an EDTA vacutainer, after which the blood samples were sent to PATHCARE diagnostic center, to determine the serum creatinine and eGFR levels. Most of the subjects were female (75.0%) while only 25.0% were males. More than one half(67.5%) of the subjects have Stage I, 21.7% have Stage 2, 7.5% were on Stage 3, 1.7% on Stage 4 and 1.7% of the subjects have Stage 5 kidney disease. The prevalence of CKD among the type 2 Diabetes Mellitus patients studied was 10.8%. There is a need for studies with larger sample size. Routine eGFR assessment after 3 months in subjects with eGFR less than 60 mL/min/1.7 m2 should be emphazisedItem The role of Nigerian Pharmacists in promoting lifestyle modification in prevention and control of hypertension.(The Pharmaceutical Society of Nigeria., 2015) Ayanniyi, R.O.; Jamiu, M.O.; Kola-Olaniyan, M.Background: Hypertension is one of the most prevalent non-communicable conditions worldwide and currently a global medical and public health issue. A public health approach to the prevention and control of hypertension needs to be adopted, one that promotes healthy dietary habits, a tobacco-free lifestyle, regular physical activity and a supportive psychosocial environment. Pharmacists and other health care professionals will play a vital role in the promotion and success of this approach, because they interact on a regular basis with a large proportion of the population and are well placed to counsel individual patients. The objective of this study was to document the role of Nigerian pharmacists in promoting lifestyle modification in the prevention and control hypertension. Methods: A descriptive cross sectional study conducted during the Annual National Conference of Pharmaceutical Society of Nigeria (2013) in Ilorin, Kwara State, Nigeria. Data was collected using semi-structured questionnaires administered to 370 Community and Hospital Pharmacists. Descriptive data was presented in the form of frequency and percentages. Statistical analysis was carried out using Chi square test and a p value of < 0.05 was considered statistically significant. Results: Three hundred and fifty questionnaires were completed giving a response rate of 94.6%. The respondents (60.3 %) performed blood pressure screening and monitoring in their practice setting while 52.9 % educate and counsel patients on life style modification. There was a significant association between Pharmacist’s educational qualifications and the provision of blood pressure screening and 2monitoring services (P=0.000) but none with patients education about life style modification (P=0.272). The Pharmacist’s area of practice was found to be significantly associated with the provision of patients education and counseling (P=0.000). Conclusion: Nigerian Pharmacists educate and counsel their patients on healthy dietary habits, dietary salt restriction, healthy body weight, regular physical activity and reduction in alcohol consumption. They also provide blood pressure screening and monitoring services to their patients.